Clinical Trial Update: Neoadjuvant Immunochemotherapy and Chemoradiotherapy Followed by Surgery for Advanced Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial conducted by National Taiwan University Hospital evaluating neoadjuvant immunochemotherapy and chemoradiotherapy followed by surgery for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: National Taiwan University Hospital | Conditions: ESCC, Total Neoadjuvant Treatment | Phase 2 | Status: RECRUITING